StonvexLoading…
StonvexStonvexStonvexCore line items from IBOC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-05 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | Not available | $214.60M | $886.27M | $662.38M | $435.61M |
Operating Income | Not available | $129.39M | $520.36M | $383.57M | $247.08M |
Net Income | Not available | $102.19M | $412.29M | $305.41M | $197.03M |
EPS (Diluted) | $1.71 | $1.64 | $6.62 | $4.91 | $3.16 |
Total Assets | Not available | $16.83B | $16.58B | $16.55B | $16.46B |
Total Liabilities | Not available | $13.54B | $13.32B | $13.42B | $13.44B |
Cash & Equivalents | Not available | $585.94M | $536.49M | $589.32M | $731.92M |
Free Cash Flow OCF − CapEx | Not available | $116.05M | $472.94M | $336.94M | $224.72M |
Shares Outstanding | Not available | 62.25M | 62.26M | 62.26M | 62.27M |